Infectious Disease

Infectious diseases include viruses, bacteria, parasites, fungi, protozoa and prions. Surveys and online discussions in this area cover subjects such as current and emerging therapies for hepatitis C; evaluation of Oritavancin, and drugs being developed against Methicillin-Resistant Staphylococcus Aureus (MRSA).

Reports that are less than a year old are highlighted in yellow. When you select the report title you will be directed to the report abstract and provided a link for purchasing the report. Reports that are over a year old are free of charge and are not highlighted. When you select the report name you will be taken directly to the report.

 

Report Name	Report Type	Specialty	Publish Date
Targanta Therapeutics IPO Panel	Discussion	Infectious Disease	Oct 4, 2007	PAID REPORT
Panel Intelligence engaged a panel of nine key opinion leaders in infectious disease to discuss Oritavancin, the primary drug in development by Targanta Therapeutics. Topics to be discussed include: Clinical opinions about Oritavancin and its potential therapeutic applications...
ICAAC 2007 Leadership Summit	Discussion	Infectious Disease	Sep 14, 2007	PAID REPORT
To discuss the latest research presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) with key opinion leaders in the field of infectious disease. ICAAC was held in Chicago from September 17-20, 2007. Review drugs being developed...
Hepatitis C: Current and Emerging Therapies	Discussion	Infectious Disease	Apr 24, 2007	FREE
Panel Intelligence engaged a group of hepatologists in an online, interactive discussion designed to: Examine ITMN-191’s strengths and weaknesses Gauge ITMN-191’s strengths and weaknesses in comparison to other promising agents in development, including: ...

 

 

about us       contact us

© Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy